Scholay

学术搜索 · AI 审稿 · LaTeX 协作

Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial

作者:Dinesh Khanna, Christopher P. Denton, Angelika Jahreis, Jacob M. van Laar, Tracy Frech, Marina Anderson, Murray Baron, Lorinda Chung, Gerhard Fierlbeck, Santhanam Lakshminarayanan, Yannick Allanore, Janet Pope, Gabriela Riemekasten, Virginia Steen, Ulf Müller‐Ladner, Robert Lafyatis, Giuseppina Stifano, Helen Spotswood, Haiyin Chen‐Harris, Sebastian Dziadek, Alyssa Morimoto, Thierry Sornasse, Jeffrey Siegel, Daniel E. Furst · 发表于:The Lancet · 年份:2016 · DOI:10.1016/s0140-6736(16)00232-4 · 被引用次数:682 · 研究领域:Systemic Sclerosis and Related Diseases、Inflammatory Myopathies and Dermatomyositis、Systemic Lupus Erythematosus Research